纳米抗体Sonelo_老虎社区_美港股上老虎 - 老虎社区

纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。具体数据什么时候公布

异动解读 | MoonLake Immunotherapeutics盘前暴跌86%，遭遇评级下调及临床试验结果不佳双重打击

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":483770727014952,"tweetId":"483770727014952","gmtCreate":1759137227911,"gmtModify":1759137230149,"author":{"id":3550916429756056,"idStr":"3550916429756056","authorId":3550916429756056,"authorIdStr":"3550916429756056","name":"小方哥哥","avatar":"https://static.tigerbbs.com/d67d618b2a23c914580657c77ce712c1","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":9,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.19","exceedPercentage":"93.93%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。具体数据什么时候公布</p></body></html>","htmlText":"<html><head></head><body><p>纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。具体数据什么时候公布</p></body></html>","text":"纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。具体数据什么时候公布","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/483770727014952","repostId":1121950852,"repostType":2,"repost":{"id":"1121950852","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1759135230,"share":"https://www.laohu8.com/m/news/1121950852?lang=&edition=full","pubTime":"2025-09-29 16:40","market":"sg","language":"zh","title":"异动解读 | MoonLake Immunotherapeutics盘前暴跌86%，遭遇评级下调及临床试验结果不佳双重打击","url":"https://stock-news.laohu8.com/highlight/detail?id=1121950852","media":"异动解读","summary":"周一盘前，生物制药公司MoonLake Immunotherapeutics股价暴跌86.24%，引起市场广泛关注。这一罕见的大幅下跌主要源于两个重要因素。RBC将MLTX的投资评级从\"跑赢大盘\"下调至\"板块表现\"，同时将目标价从67美元大幅下调至10美元，降幅高达85%。这一举动严重打击了投资者信心，导致股价大幅下挫。其次，公司最新发布的临床试验结果令人失望。这两个因素叠加，导致MLTX股价在盘前交易中遭遇近乎腰斩的暴跌。","content":"<p>周一盘前，生物制药公司MoonLake Immunotherapeutics（MLTX）股价暴跌86.24%，引起市场广泛关注。这一罕见的大幅下跌主要源于两个重要因素。</p>\n\n<p>首先，加拿大皇家银行（RBC）大幅下调了对MLTX的评级和目标价。RBC将MLTX的投资评级从\"跑赢大盘\"下调至\"板块表现\"，同时将目标价从67美元大幅下调至10美元，降幅高达85%。这一举动严重打击了投资者信心，导致股价大幅下挫。</p>\n\n<p>其次，公司最新发布的临床试验结果令人失望。MLTX公布了其Vela三期临床项目的第16周试验结果，该项目正在评估纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。虽然具体数据尚未公开，但市场反应表明，这些结果可能未能达到预期，进一步加剧了投资者的担忧。这两个因素叠加，导致MLTX股价在盘前交易中遭遇近乎腰斩的暴跌。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | MoonLake Immunotherapeutics盘前暴跌86%，遭遇评级下调及临床试验结果不佳双重打击</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | MoonLake Immunotherapeutics盘前暴跌86%，遭遇评级下调及临床试验结果不佳双重打击\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-09-29 16:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>周一盘前，生物制药公司MoonLake Immunotherapeutics（MLTX）股价暴跌86.24%，引起市场广泛关注。这一罕见的大幅下跌主要源于两个重要因素。</p>\n\n<p>首先，加拿大皇家银行（RBC）大幅下调了对MLTX的评级和目标价。RBC将MLTX的投资评级从\"跑赢大盘\"下调至\"板块表现\"，同时将目标价从67美元大幅下调至10美元，降幅高达85%。这一举动严重打击了投资者信心，导致股价大幅下挫。</p>\n\n<p>其次，公司最新发布的临床试验结果令人失望。MLTX公布了其Vela三期临床项目的第16周试验结果，该项目正在评估纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。虽然具体数据尚未公开，但市场反应表明，这些结果可能未能达到预期，进一步加剧了投资者的担忧。这两个因素叠加，导致MLTX股价在盘前交易中遭遇近乎腰斩的暴跌。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MLTX":"MoonLake Immunotherapeutics"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121950852","content_text":"周一盘前，生物制药公司MoonLake Immunotherapeutics（MLTX）股价暴跌86.24%，引起市场广泛关注。这一罕见的大幅下跌主要源于两个重要因素。\n首先，加拿大皇家银行（RBC）大幅下调了对MLTX的评级和目标价。RBC将MLTX的投资评级从\"跑赢大盘\"下调至\"板块表现\"，同时将目标价从67美元大幅下调至10美元，降幅高达85%。这一举动严重打击了投资者信心，导致股价大幅下挫。\n其次，公司最新发布的临床试验结果令人失望。MLTX公布了其Vela三期临床项目的第16周试验结果，该项目正在评估纳米抗体Sonelokimab在治疗化脓性汗腺炎（HS）方面的疗效。虽然具体数据尚未公开，但市场反应表明，这些结果可能未能达到预期，进一步加剧了投资者的担忧。这两个因素叠加，导致MLTX股价在盘前交易中遭遇近乎腰斩的暴跌。","news_type":1,"symbols_score_info":{"MLTX":1}},"isVote":1,"tweetType":1,"viewCount":472,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":72,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/483770727014952"}